Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy

Photodiagnosis and Photodynamic Therapy

Volumn 5, Issue 3, 2008, Pages 210-216

  Ascencio, Manuel ^a   Estevez, Juan Pablo ^a   Delemer, Marie ^a   Farine, Marie Odile ^a   Collinet, Pierre ^a   Mordon, Serge ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Fractionated; Hexaminolaevulinate; Ovarian cancer; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; PROTOPORPHYRIN;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOMATOUS PERITONITIS; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HISTOLOGY; ILLUMINATION; LASER; NONHUMAN; OVARY CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RAT; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR NECROSIS;

AMINOLEVULINIC ACID; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; LIGHT; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEUM; PHOTOCHEMOTHERAPY; RATS;

RATTUS;

EID: 56449106562     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2008.09.004     Document Type: Article

References (55)

1. Benedet J.L., Bender H., Jones III H., et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70 2 (2000) 209-262
2. Rensontet A., Velten M., Jougla E., et al. Evolution de l'incidence et de la mortalité par cancer en france de 1978 à 2000. Actis-Paris (2003) 119-124
3. Eisenkop S.M., Nalick R.H., Wang H.J., et al. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol 51 2 (1993) 224-229
4. McCarron P.A., Donnelly R.F., Zawislak A., et al. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm 293 1-2 (2005) 11-23
5. McCarron P.A., Ma L.W., Juzenas P., et al. Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems. J Environ Pathol Toxicol Oncol 25 1-2 (2006) 389-402
6. 2 vaporization: retrospective study of 52 cases. J Gynecol Obstet Biol Reprod (Paris) 35 8 Pt 1 (2006) 785-789
7. Yamaguchi S., Tsuda H., Takemori M., et al. Photodynamic therapy for cervical intraepithelial neoplasia. Oncology 69 2 (2005) 110-116
8. Hillemanns P., Wang X., Staehle S., et al. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol 100 2 (2006) 271-275
9. Zaak D., Sroka R., Stocker S., et al. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX-in vivo experiments on the dunning rat tumor model. Urol Int 72 3 (2004) 196-202
10. El Khatib S., Didelon J., Leroux A., et al. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. J Urol 172 5 Pt 1 (2004) 2013-2017
11. Gossner L., Sroka R., Hahn E.G., et al. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc 41 1 (1995) 55-58
12. Pech O., Gossner L., May A., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 1 (2005) 24-30
13. Regula J., Ravi B., Bedwell J., et al. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer-prolonged animal survival. Br J Cancer 70 2 (1994) 248-254
14. Ziolkowski P., Osiecka B.J., Oremek G., et al. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J Exp Ther Oncol 4 2 (2004) 121-129
15. Betz C.S., Lai J.P., Xiang W., Janda P., et al. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci 1 5 (2002) 315-319
16. Kennedy J.C., and Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14 4 (1992) 275-292
17. Loning M.C., Diddens H.C., Holl-Ulrich K., et al. Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid: fluorescence microscopy studies. Lasers Surg Med 38 June (5) (2006) 549-554
18. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6 1-2 (1990) 143-148
19. Meijinders P., Star W., and De Bruijn R. Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolevulinic acid. Lasers 11 (1996) 121-131
20. Lopez R.F., Lange N., Guy R., et al. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv Drug Deliv Rev 56 1 (2004) 77-94
21. Wyld L., Burn J.L., Reed M.W., et al. Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br J Cancer 76 6 (1997) 705-712
22. Leibovici L., Schoenfeld N., Yehoshua H.A., et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer 62 11 (1988) 2297-2300
23. el-Sharabasy M.M., el-Waseef A.M., Hafez M.M., et al. Porphyrin metabolism in some malignant diseases. Br J Cancer 65 3 (1992) 409-412
24. Brunner H., Hausmann F., and Knuechel R. New 5-aminolevulinic acid esters-efficient protoporphyrin precursors for photodetection and photodynamic therapy. Photochem Photobiol 78 5 (2003) 481-486
25. Lange N., Jichlinski P., Zellweger M., et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 80 1-2 (1999) 185-193
26. Jouve E, Collinet P, Delemer-Lefebvre M, et al. Alternative administrations of hexaminolevulinate (HeALA) for laparoscopic fluorescence diagnosis of metastatic ovarian cancer in a rat model. In: 15th annual congress of the european society for gynaecological endoscopy; 2006; Strasbourg: Medimond International Proceedings; 2006.
27. Regis C., Collinet P., Farine M.O., et al. Comparison of aminolevulinic acid- and hexylester aminolevulinate-induced protoporphyrin IX fluorescence for the detection of ovarian cancer in a rat model. Photomed Laser Surg 25 4 (2007) 304-311
28. Hua Z., Gibson S.L., Foster T.H., et al. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 55 8 (1995) 1723-1731
29. Messmann H., Mlkvy P., Buonaccorsi G., et al. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer 72 3 (1995) 589-594
30. Pogue B.W., and Hasan T. A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. Radiat Res 147 5 (1997) 551-559
31. Rose G.S., Tocco L.M., Granger G.A., et al. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol 175 3 Pt 1 (1996) 593-599
32. Ascencio M., Delemer-Lefebvre M., Farine M.O., et al. Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model. Photodiag Photodyn Ther 4 4 (2007) 254-260
33. Foster T.H., Murant R.S., Bryant R.G., et al. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 126 3 (1991) 296-303
34. Hornung R., Fink D., Dobler-Girdziunaite D., et al. Photodynamic therapy for the hypercalcemic type of the small cell carcinoma of the ovary in a mouse xenograft model. Gynecol Oncol 75 3 (1999) 447-452
35. Major A.L., Rose G.S., Svaasand L.O., et al. Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: a toxicity study. J Photochem Photobiol B 66 2 (2002) 107-114
36. Fotinos N., Campo M.A., Popowycz F., et al. 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives. Photochem Photobiol 82 4 (2006) 994-1015
37. Marti A., Jichlinski P., Lange N., et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 170 2 Pt 1 (2003) 428-432
38. Ludicke F., Gabrecht T., Lange N., et al. Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study. Br J Cancer 88 11 (2003) 1780-1784
39. Dougherty T.J. Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol 2 2 (1984) 83-116
40. McCaughan Jr. J.S., Hicks W., Laufman L., et al. Palliation of esophageal malignancy with photoradiation therapy. Cancer 54 12 (1984) 2905-2910
41. Grosjean P., Wagnieres G., Fontolliet C., et al. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer 77 11 (1998) 1989-1995
42. Etienne J., Dorme N., Bourg-Heckly G., et al. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 59 7 (2004) 880-889
43. van den Boogert J., van Staveren H.J., de Bruin R.W., et al. Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation. Lasers Med Sci 16 1 (2001) 16-25
44. Boere I.A., Robinson D.J., de Bruijn H.S., et al. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol 82 6 (2006) 1638-1644
45. Mlkvy P., Messmann H., Pauer M., et al. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer 73 12 (1996) 1473-1479
46. Muller S., Walt H., Dobler-Girdziunaite D., et al. Enhanced photodynamic effects using fractionated laser light. J Photochem Photobiol B 42 1 (1998) 67-70
47. Pe M.B., Ikeda H., and Inokuchi T. Tumour destruction and proliferation kinetics following periodic, low power light, haematoporphyrin oligomers mediated photodynamic therapy in the mouse tongue. Eur J Cancer B: Oral Oncol 30B 3 (1994) 174-178
48. van der Veen N., van Leengoed H.L., and Star W.M. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer 70 5 (1994) 867-872
49. Curnow A., McIlroy B.W., Postle-Hacon M.J., et al. Light dose fractionation to enhance photodynamic therapy using 5-aminolevulinic acid in the normal rat colon. Photochem Photobiol 69 1 (1999) 71-76
50. Curnow A., MacRobert A.J., and Bown S.G. Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid. Lasers Surg Med 38 4 (2006) 325-331
51. Iinuma S., Schomacker K.T., Wagnieres G., et al. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res 59 24 (1999) 6164-6170
52. Curnow A., Haller J.C., and Bown S.G. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. J Photochem Photobiol B 58 2-3 (2000) 149-155
53. Curnow A., and Bown S.G. The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid-a study on normal rat colon. Br J Cancer 86 6 (2002) 989-992
54. Dietel W., Pottier R., Pfister W., et al. 5-Aminolaevulinic acid (ALA) induced formation of different fluorescent porphyrins: a study of the biosynthesis of porphyrins by bacteria of the human digestive tract. J Photochem Photobiol B 86 1 (1997) 77-86
55. Juzeniene A., Juzenas P., Iani V., et al. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol 76 3 (2002) 329-334